Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoviridae Infections × Vaccines × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1 Adenoviridae Infections 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03384316 2020-09-09

Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

11 enrolled 18 charts

BreastGastrointestinalGenitourinaryThoracic

Adenoviridae Infections, Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡